Clinical trial
SELECT (semaglutide 2.4 mg), frailty post-hoc analysis
NCT03574597
Post-hoc RCT analysis, n=17 604, JAMA Cardiology 16.09.2026.
No news refers to this card yet.
Also in the catalogue
- PIEZO-101 (Piezo Therapeutics)Clinical trial
- SECURE polypillClinical trial
- Finerenone vs placebo in premature ovarian insufficiencyClinical trial
- SOUL (oral semaglutide)Clinical trial
- First-in-human: autologous bone-marrow MSC infusion in severe osteoporosisClinical trial
- FIDELIO-DKD (finerenone)Clinical trial
Scales
Identifiers
- NCT
- NCT03574597
Original sources
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.